- Trials with a EudraCT protocol (215)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
215 result(s) found for: Chronic depression.
Displaying page 1 of 11.
EudraCT Number: 2016-001637-27 | Sponsor Protocol Number: LQD | Start Date*: 2016-09-20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Treatment resistant major depressive disorder (single episode or recurrent). Treatment resistant depression, defined as failure to respond to two or more adequate doses of antidepressant in the cur... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005372-34 | Sponsor Protocol Number: UMCN-AKF12.02 | Start Date*: 2013-06-26 | ||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | ||||||||||||||||||
Full Title: The role of paroxetine in patients taking telaprevir-based HCV therapy: lack of a drug-drug interaction? (ROLEX) | ||||||||||||||||||
Medical condition: chronic hepatitis C infection with depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002157-51 | Sponsor Protocol Number: 1034-PhII | Start Date*: 2005-08-03 | |||||||||||
Sponsor Name:Antares Pharma AG | |||||||||||||
Full Title: A Phase II, Single-Center, Open-Label, Parallel, Three-Treatment, Single-Period, Randomized, Single and Multiple-Dose Pharmacokinetic Study of Oxybutynin Gel in Healthy Volunteers | |||||||||||||
Medical condition: Study design according to CPMP/EWP/QWP/1401/98 and CPMP/EWP/280/96. Using an open-label, three-treatment, dose-ranging, single-period, randomized, single and multiple-dose design, three treatments ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005206-37 | Sponsor Protocol Number: CNTO136MDD2001 | Start Date*: 2015-09-14 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a MonoAminergic antidepressant in Adults with Major Depressive Disorder | |||||||||||||
Medical condition: Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018064-95 | Sponsor Protocol Number: S52151 | Start Date*: 2012-06-18 |
Sponsor Name:University of Leuven | ||
Full Title: Amyloid imaging in late life depression | ||
Medical condition: Late life depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001692-37 | Sponsor Protocol Number: ketamine_plus_CBASP | Start Date*: 2021-02-24 | |||||||||||
Sponsor Name:University Hospital Tuebingen | |||||||||||||
Full Title: Pharmacologic treatment augmentation in chronic depression randomized, controlled, double blinded, phase II study | |||||||||||||
Medical condition: Males and females between 18-64 years with a diagnosis of chronic depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001997-70 | Sponsor Protocol Number: EXCELLENCE/0421/0543v1 | Start Date*: 2022-11-16 | ||||||||||||||||||||||||||
Sponsor Name:University of Cyprus | ||||||||||||||||||||||||||||
Full Title: Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD) | ||||||||||||||||||||||||||||
Medical condition: Methadone and buprenorphine comprise a first-line, evidence-based opioid substitution treatment (OST) for OUD patients. Unfortunately, retention and adherence to OST treatment is currently a major ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: CY (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004210-26 | Sponsor Protocol Number: 14/0647 | Start Date*: 2016-11-22 | |||||||||||
Sponsor Name:PRIMENT Clinical Trials Unit, UCL | |||||||||||||
Full Title: A Phase IV double blind multi-site, individually randomised parallel group controlled trial investigating the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in pati... | |||||||||||||
Medical condition: Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006914-41 | Sponsor Protocol Number: CBASP-1 | Start Date*: 2008-09-29 |
Sponsor Name:Dept. of Psychiaty, University of Freiburg | ||
Full Title: Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus escitalopram in chronic major depression with and without early trauma | ||
Medical condition: Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus Escitalopram in chronic major depression with and without early trauma. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000453-35 | Sponsor Protocol Number: EPO-AD-01-2008 | Start Date*: 2008-06-30 | ||||||||||||||||
Sponsor Name:Max-Planck-Institute of Experimental Medicine | ||||||||||||||||||
Full Title: Open-label phase IIa pilot study exploring safety and potential efficacy of recombinant human erythropoietin in early mild Alzheimer Dementia and therapy-refractory Major Depression (“EPO-AD”) | ||||||||||||||||||
Medical condition: Early, mild dementia of the Alzheimer’s Type and therapy-refractory Major Depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005534-20 | Sponsor Protocol Number: 05102006 | Start Date*: 2008-01-24 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Effect of Erdosteine on inflammatory and oxidative biomarkers in sputum and exhaled breath in patients with COPD | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) of different severity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005200-15 | Sponsor Protocol Number: 6096-022 | Start Date*: 2012-05-14 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase IIa, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 for Treatment Augmentation in Patients with Major Depressive Disorder. | |||||||||||||
Medical condition: depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) SE (Completed) NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000547-27 | Sponsor Protocol Number: CTIMPMCRENAL12 | Start Date*: 2012-11-01 | |||||||||||||||||||||
Sponsor Name:East and North Hertfordshire NHS Trust [...] | |||||||||||||||||||||||
Full Title: A Pilot Randomised Controlled Trial of Drug Treatment for Depression in Patients undergoing Haemodialysis | |||||||||||||||||||||||
Medical condition: Major Depressive Disorder in Patients with End Stage Renal Disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-006609-25 | Sponsor Protocol Number: MOOD-HF | Start Date*: 2008-05-27 | |||||||||||
Sponsor Name:Julius Maximilians Universität Würzburg | |||||||||||||
Full Title: Effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in Depressed Heart Failure patients | |||||||||||||
Medical condition: To investigate the effects of selective serotonin re-uptake inhibition with the SSRI escitalopram on morbidity and mortality in depressed patients with CHF. The primary endpoint is the time to a fi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000425-22 | Sponsor Protocol Number: 68-4986/12484 | Start Date*: 2007-12-19 | |||||||||||
Sponsor Name:Bayer Healthcare AG | |||||||||||||
Full Title: Phase IIa Efficacy and Safety Trial of capadenoson in Patients with Chronic Stable Angina | |||||||||||||
Medical condition: Patients with Chronic Stable Angina | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020956-69 | Sponsor Protocol Number: OX02 | Start Date*: 2011-02-23 | ||||||||||||||||
Sponsor Name:Universitätsklinikum Freiburg | ||||||||||||||||||
Full Title: Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung | ||||||||||||||||||
Medical condition: ICD-10 F60.3 Emotionally unstable personality disorder Two types may be distinguished: the impulsive type, characterized by emotional instability and lack of impulse control, and the borderline typ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004780-34 | Sponsor Protocol Number: A7571001 | Start Date*: 2006-04-18 | |||||||||||
Sponsor Name:Pfizer Ltd, Sandwich, UK | |||||||||||||
Full Title: An eight-week, double-blind, group sequential design, placebo controlled trial to evaluate the safety and efficacy of the co-administration of sertraline and elzasonan (CP-448,187) in outpatients w... | |||||||||||||
Medical condition: Major Depressive Disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010188-18 | Sponsor Protocol Number: 26859 | Start Date*: 2010-07-01 |
Sponsor Name:Eli Lilly Nederland | ||
Full Title: Effectiveness of Transmural Collaborative care and Duloxetine for major depressive disorder and (sub)chronic pain: a randomized placebo-controlled Multi-Centre trial. | ||
Medical condition: Major depressive disorder (episode or recurrent), as principal DSM-IV diagnosis combined with (sub)chronic pain symptoms as defined bij score of >3 on BPI painlist for at least six weeks. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000222-11 | Sponsor Protocol Number: 1 | Start Date*: 2016-02-04 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A phase II, randomised, double-blind, placebo- controlled, multi-site, parallel group clinical trial to examine ketamine as a pharmacological treatment for alcohol dependence in an alcohol dependen... | |||||||||||||
Medical condition: Severe Alcohol Use Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015837-55 | Sponsor Protocol Number: RAA09-004 | Start Date*: 2010-08-17 | |||||||||||
Sponsor Name:Kings College London [...] | |||||||||||||
Full Title: Double-blind, 36 month, placebo-controlled trial of mifepristone on cognition in alcoholics | |||||||||||||
Medical condition: Alcoholism | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
